X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gut-liver axis (132) 132
index medicus (84) 84
microbiota (43) 43
inflammation (39) 39
gastroenterology & hepatology (37) 37
humans (37) 37
gut microbiota (36) 36
animals (32) 32
liver (32) 32
gut–liver axis (31) 31
liver diseases (31) 31
bacterial translocation (22) 22
mice (22) 22
obesity (21) 21
male (20) 20
cirrhosis (19) 19
digestive system (19) 19
intestinal microbiota (19) 19
non-alcoholic fatty liver disease (19) 19
probiotics (19) 19
fatty liver (18) 18
review (18) 18
dysbiosis (17) 17
nafld (16) 16
oxidative stress (16) 16
article (15) 15
steatohepatitis (15) 15
analysis (14) 14
injury (14) 14
insulin-resistance (14) 14
intestinal permeability (14) 14
liver - metabolism (14) 14
microbiome (14) 14
biochemistry & molecular biology (13) 13
gastrointestinal microbiome (13) 13
intestine (13) 13
nonalcoholic steatohepatitis (13) 13
pathogenesis (12) 12
permeability (12) 12
disease (11) 11
fatty liver-disease (11) 11
metabolism (11) 11
pharmacology & pharmacy (11) 11
alcohol (10) 10
bile acids (10) 10
digestive tract (10) 10
female (10) 10
health aspects (10) 10
liver - pathology (10) 10
liver cirrhosis (10) 10
nonalcoholic fatty liver disease (10) 10
rats (10) 10
research (10) 10
toll-like receptors (10) 10
activation (9) 9
diet (9) 9
diet-induced obesity (9) 9
endotoxemia (9) 9
fibrosis (9) 9
hepatitis (9) 9
hepatocellular-carcinoma (9) 9
insulin resistance (9) 9
nutrition & dietetics (9) 9
axis (8) 8
bacteria (8) 8
cancer (8) 8
dysbacteriosis (8) 8
intestinal barrier (8) 8
medicine, research & experimental (8) 8
metabolites (8) 8
nf-kappa-b (8) 8
physiological aspects (8) 8
primary sclerosing cholangitis (8) 8
risk factors (8) 8
development and progression (7) 7
disease models, animal (7) 7
expression (7) 7
farnesoid x receptor (7) 7
gut dysbiosis (7) 7
hepatocellular carcinoma (7) 7
innate immunity (7) 7
intestines - microbiology (7) 7
liver - drug effects (7) 7
portal vein (7) 7
surgery (7) 7
adult (6) 6
antibiotics (6) 6
bile (6) 6
bile acid (6) 6
bile acids and salts - metabolism (6) 6
biology (6) 6
cell biology (6) 6
cells (6) 6
chemistry, multidisciplinary (6) 6
cytokines (6) 6
digestive system diseases (6) 6
double-blind (6) 6
farnesoid-x-receptor (6) 6
hepatic steatosis (6) 6
hepatic-encephalopathy (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of burn care & research : official publication of the American Burn Association, ISSN 1559-047X, 2017, Volume 38, Issue 1, pp. e144 - e157
The widespread and rapidly increasing trend of binge drinking is accompanied by a concomitant rise in the prevalence of trauma patients under the influence of... 
trauma | burn | Alcohol | gut-liver axis
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 10/2019, Volume 25, Issue 39, pp. 5897 - 5917
Portal hypertension (PHT) in advanced chronic liver disease (ACLD) results from increased intrahepatic resistance caused by pathologic changes of liver tissue... 
Farnesoid X receptor | Cirrhosis | Intestinal barrier | Portal hypertension | Review | Bacterial translocation | Gut-liver axis
Journal Article
Journal of hepatology, ISSN 0168-8278, 10/2018, Volume 69, Issue 4, pp. 886 - 895
A schematic diagram illustrating the proposed mechanism by which intestinal HIF-1α depletion exacerbates alcoholic liver disease. AMP: antimicrobial peptide,... 
Hypoxia Inducible Factor-1α | Gut Microbiota | Intestinal Barrier | Alcoholic Liver Disease | Gut-Liver axis
Journal Article
International Journal of Biological Macromolecules, ISSN 0141-8130, 12/2019, Volume 141, pp. 1013 - 1021
MDG-1, a β-D-fructan polysaccharide extracted from the roots of , had preventive effect against obesity and hyperlipidemia in high-fat diet (HFD)-induced... 
Non-alcoholic fatty liver disease | MDG-1 | Gut-liver axis
Journal Article
Orvosi Hetilap, ISSN 0030-6002, 07/2017, Volume 158, Issue 26, pp. 1014 - 1021
Journal Article
FASEB Journal, ISSN 0892-6638, 12/2018, Volume 32, Issue 12, pp. 6681 - 6693
The gut microbiota regulates key hepatic functions, notably through the production of bacterial metabolites that are transported via the portal circulation. We... 
Gut–liver axis | Cholesterol metabolism | LPS | Kupffer cells | PCLS | CHOLESTEROL | TRYPTOPHAN-METABOLITES | cholesterol metabolism | HIGH-FAT DIET | BIOCHEMISTRY & MOLECULAR BIOLOGY | SUSCEPTIBILITY | HOST | CELL BIOLOGY | INDOXYL SULFATE | gut-liver axis | ARYL-HYDROCARBON RECEPTOR | DISEASE | BIOLOGY | EXPRESSION | OXYSTEROLS | Research | gut–liver axis
Journal Article
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 02/2019, Volume 509, Issue 3, pp. 767 - 772
In the past decade, research on the biology of the gut-liver axis has assisted in understanding the basic biology of nonalcoholic fatty liver disease (NAFLD).... 
Nonalcoholic fatty liver disease | HMGB1 | Dysbiosis | Exosome | Gut-liver axis | ACTIVATION | NAFLD | BIOPHYSICS | BIOCHEMISTRY & MOLECULAR BIOLOGY | INJURY | MICROBIOTA
Journal Article
DMM Disease Models and Mechanisms, ISSN 1754-8403, 05/2019, Volume 12, Issue 5, p. dmm039206
Childhood obesity has reached epidemic levels, representing one of the most serious public health concerns associated with metabolic syndrome and non-alcoholic... 
Childhood obesity | Metabolic syndrome | Intestinal microbiota | Fecal metabolome | Gut-liver axis | 310 | 303 | 306
Journal Article
Journal of Functional Foods, ISSN 1756-4646, 10/2019, Volume 61, p. 103458
(DOF) is a Traditional Chinese edible and bioavailable plant. The aim of this study was to investigate the hepatoprotective effects of DOF ultrafine powder... 
Dendrobii Officinalis | Nonalcoholic fatty liver disease (NAFLD) | Ultrafine powder | TLR4 | LPS | Gut-liver axis
Journal Article
Journal of Hepatology, ISSN 0168-8278, 10/2018, Volume 69, Issue 4, pp. 886 - 895
Alcoholic liver disease (ALD) is characterized by gut dysbiosis and increased gut permeability. Hypoxia inducible factor 1α (HIF-1α) has been implicated in... 
Gut-Liver axis | Gut Microbiota | Intestinal Barrier | Hypoxia-Inducible Factor-1α | Alcoholic Liver Disease | PROTECTS MICE | MURINE COLITIS | AKKERMANSIA-MUCINIPHILA | INJURY | FACTOR-I | HYPOXIA | Hypoxia-Inducible Factor-1 alpha | CHAIN FATTY-ACIDS | THERAPEUTIC TARGETS | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | T-CELLS
Journal Article
World Journal of Hepatology, ISSN 1948-5182, 2015, Volume 7, Issue 3, pp. 425 - 442
A "leaky gut" may be the cutting edge for the passage of toxins, antigens or bacteria into the body, and may play a pathogenic role in advanced liver cirrhosis... 
Selective intestinal decontamination | Probiotics | Complications | Pathogenesis | Toll-like receptors | Liver cirrhosis | Bacterial translocation | Endotoxemia | Gut-liver axis | Leaky gut | Review
Journal Article
Pharmacological Research, ISSN 1043-6618, 02/2020, Volume 152, p. 104617
Increased interest in understanding the liver-kidney axis in health and disease during the last decade unveiled multiple recent evidence that suggested a... 
Gut microbiota | NAFLD | Liver-kidney axis | Fibrosis | Insulin resistance | Inflammation | NASH | Gut-kidney axis | Intestinal barrier integrity | CKD | Gut-liver axis
Journal Article
Journal of Hepatology, ISSN 0168-8278, 12/2019, Volume 71, Issue 6, pp. 1126 - 1140
Pathological bacterial translocation (PBT) in cirrhosis is the hallmark of spontaneous bacterial infections, increasing mortality several-fold. Increased... 
FXR | Gut-vascular barrier | Portal hypertension | Intestinal permeability | Mucus | Liver cirrhosis | Gut-liver axis | MUC2 MUCIN | OBETICHOLIC ACID | COLON | VESICLE-ASSOCIATED PROTEIN | DEFICIENCY | GOBLET CELLS | FARNESOID-X-RECEPTOR | MICE | GASTROENTEROLOGY & HEPATOLOGY | PORTAL-HYPERTENSION | AGONIST
Journal Article